Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Extracellular matrix in lung development, homeostasis and disease
The lung's unique extracellular matrix (ECM), while providing structural support for cells, is
critical in the regulation of developmental organogenesis, homeostasis and injury-repair …
critical in the regulation of developmental organogenesis, homeostasis and injury-repair …
An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy
G Kurland, RR Deterding, JS Hagood… - American journal of …, 2013 - atsjournals.org
Background: There is growing recognition and understanding of the entities that cause
interstitial lung disease (ILD) in infants. These entities are distinct from those that cause ILD …
interstitial lung disease (ILD) in infants. These entities are distinct from those that cause ILD …
Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society
Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …
diseases in neonates, infants, and older children and contributes to significant morbidity and …
[HTML][HTML] Human inherited CCR2 deficiency underlies progressive polycystic lung disease
We describe a human lung disease caused by autosomal recessive, complete deficiency of
the monocyte chemokine receptor CC motif chemokine receptor 2 (CCR2). Nine children …
the monocyte chemokine receptor CC motif chemokine receptor 2 (CCR2). Nine children …
European protocols for the diagnosis and initial treatment of interstitial lung disease in children
A Bush, S Cunningham, J De Blic, A Barbato… - Thorax, 2015 - thorax.bmj.com
Interstitial lung disease in children (chILD) is rare, and most centres will only see a few
cases/year. There are numerous possible underlying diagnoses, with specific and non …
cases/year. There are numerous possible underlying diagnoses, with specific and non …
Emergent high fatality lung disease in systemic juvenile arthritis
VE Saper, G Chen, GH Deutsch… - Annals of the …, 2019 - ard.bmj.com
Objective To investigate the characteristics and risk factors of a novel parenchymal lung
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In …
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In …
Pulmonary alveolar proteinosis
In acquired pulmonary alveolar proteinosis, lipids and proteins accumulate within the alveoli
because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …
because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …
Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease
JA Whitsett, SE Wert, TE Weaver - Annual review of medicine, 2010 - annualreviews.org
The alveolar region of the lung creates an extensive epithelial surface that mediates the
transfer of oxygen and carbon dioxide required for respiration after birth. Maintenance of …
transfer of oxygen and carbon dioxide required for respiration after birth. Maintenance of …
Autoimmune pulmonary alveolar proteinosis
Autoimmune pulmonary alveolar proteinosis (PAP) is a rare disease characterized by
myeloid cell dysfunction, abnormal pulmonary surfactant accumulation, and innate immune …
myeloid cell dysfunction, abnormal pulmonary surfactant accumulation, and innate immune …
Pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease characterised by alveolar
accumulation of surfactant. It may result from mutations in surfactant proteins or granulocyte …
accumulation of surfactant. It may result from mutations in surfactant proteins or granulocyte …